ChemicalBook > CAS DataBase List > Sulconazle Nitrate

Sulconazle Nitrate

CAS No.82382-23-8
Chemical Name:Sulconazle Nitrate
CBNumber:CB02131212
Molecular Formula:C18H15Cl3N2S.HNO3
Formula Weight:460.76
MOL File:82382-23-8.mol

Sulconazle Nitrate Property

Melting point 148-153°C
storage temp. Refrigerator
solubility Acetonitrile (Slightly, Heated), Methanol (Slightly), Water (Slightly)
form Solid
color White to Off-White
CAS DataBase Reference 82382-23-8
FDA UNII 1T89100D5U

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Hazard statements
Precautionary statements

Sulconazle Nitrate Chemical Properties,Usage,Production

Description Sulconazole nitrate is an imidazole antifungal agent closely related to econazole. It is effective in the topical treatment of a broad spectrum of superficial fungal infections.
Originator Syntex (USA)
Uses Antifungal.
Definition ChEBI: Sulconazole nitrate is an organic nitrate salt, a conazole antifungal drug and an imidazole antifungal drug.
brand name Exelderm (Westwood-Squibb).
Biological Activity Sulconazole Nitrate is an imidazole derivative with broad-spectrum antifungal activity.
Clinical Use 1-[2,4-Dichloro-β-[p-chlorobenzyl)thio]phenethyl]imidazolemononitrate (Exelderm) is the white crystalline nitricacid salt of sulconazole. It is sparingly soluble in water butsoluble in ethanol. The salt is used in a solution and a cream in 1% concentration for the treatment of local tinea infections,such as jock itch, athlete’s foot, and ringworm.
in vitro Sulconazole Nitrate possesses a broad spectrum of activity in vitro against dermatophytes, yeasts and some Gram-positive bacteria at concentrations below 5 mg/L in vitro. It has been shown that against representatives of pathogenic yeasts, dermatophytes and Aspergilli, the RIF values of sulconazole are broadly similar to those of other imidazoles. The fungicidal potency of sulconazole in vitro depends on its concentration and on the growth phase of the inoculum cells. Sulconazole has also demonstrated antibacterial activity in vitro, with MIC values below 12.5 mg/L.
in vivo The efficacy and safety of sulconazole 1% cream has been demonstrated in controlled clinical studies in patients with superficial dermatophyte or yeast infections. To minimise the risk of reinfection treatment should continue for 3 weeks in Candida infections, tinea cruris, tinea corporis and pityriasis versicolor, and for 4 weeks in patients with tinea pedis.